Researchers in Japan report that LPC70, a compound extracted from soy, appears to counter some of the cardiovascular and cognitive damage caused by a high-salt diet in mice. An earlier study had already found that LPC70 lowered blood pressure and reduced memory and social problems in these animals. The new work, published in Neurochemistry International, tries to explain how it does this.
The team, led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota at Fujita Health University with Dr. Kazuhiro Kagotani, focused on prostaglandins, signaling molecules made from the fatty acid arachidonic acid. Prostaglandins help regulate blood vessel tone throughout the body, and in the brain they can either protect nerve cells or contribute to harmful processes, depending on which receptors they activate.
Mice on a high-salt diet developed high blood pressure and became less socially interactive, with trouble recognizing objects they had seen before. Their general movement and anxiety-like behavior did not change much, which the authors read as salt selectively disrupting complex cognitive and social functions. When LPC70 was added to their diet, blood pressure improved and the animals did better on social and object recognition tests.
The mechanism differed by organ. In the kidneys, excess salt raised levels of COX-2 and the EP3 receptor, both linked to salt-related hypertension, and LPC70 reduced those increases. In the prefrontal cortex, salt lowered expression of the DP1 receptor, which is involved in protective and anti-inflammatory signaling, and LPC70 restored it without changing DP2, a receptor associated with potentially harmful effects. The compound also appeared to raise levels of prostaglandins made from arachidonic acid, even though circulating arachidonic acid had dropped on the high-salt diet, suggesting more efficient use of that fatty acid.
The researchers describe LPC70 as a possible functional food ingredient for reducing some effects of excess salt intake. That conclusion rests entirely on animal experiments, and the authors state that clinical studies are needed to determine whether the same benefits occur in humans. The work was funded in part by Tsuji Oil Mills Co., Ltd., which develops naturally derived food ingredients.